Rizatriptan Benzoate Tablet
Product Images NDC 29300-317
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 29300-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Db8f9f09 0af5 4528 A7af 831c2d861375 02
The text describes a graph showing the estimated probability of response to different doses of Rizatriptan Benzoate Tablets, USP. The graph shows the probability of response at different time intervals post-dose. Unfortunately, there is no additional information to give a more detailed description.*
Db8f9f09 0af5 4528 A7af 831c2d861375 03
Db8f9f09 0af5 4528 A7af 831c2d861375 04
Db8f9f09 0af5 4528 A7af 831c2d861375 05
Db8f9f09 0af5 4528 A7af 831c2d861375 06
This appears to be a chart or graph related to the effectiveness of Rizatriptan Benzoate Orally Disintegrating Tablets compared to a placebo. The x-axis seems to represent the time elapsed (in hours) after taking the medication, while the y-axis is not visible in the provided text. The title of the chart appears to be "Percent (35% C1)" and it shows data points for both the medication and the placebo at various time intervals. Without more information, it is unclear what the 35% C1 refers to.*
Db8f9f09 0af5 4528 A7af 831c2d861375 07
Db8f9f09 0af5 4528 A7af 831c2d861375 08
Db8f9f09 0af5 4528 A7af 831c2d861375 09
Db8f9f09 0af5 4528 A7af 831c2d861375 10
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.